Takeaway

• The Danish Cardiovascular Screening (DANCAVAS) trial did not show any benefit of comprehensive image-based cardiovascular (CV) screening on all-cause mortality among men aged 65-74 years; however, sub-group analysis revealed the benefits of screening among the younger participants (age, 65-69 years).

Why this matters

• CV diseases are the main cause...